Sana Biotechnology, Inc. (SANA) Social Stream
Sana Biotechnology Inc (SANA) Price Targets From Analysts
Use the tables below to see what analysts covering Sana Biotechnology Inc think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-09 | 3 | $45 | $31 | $38.666 | $8.68 | 345.46% |
2022-01-05 | 3 | $40 | $31 | $37 | $8.68 | 326.27% |
2022-02-03 | 3 | $40 | $17 | $29.333 | $8.68 | 237.94% |
2022-03-18 | 3 | $40 | $14 | $23.666 | $8.68 | 172.65% |
2022-03-29 | 3 | $32 | $14 | $21 | $8.68 | 141.94% |
The Trend in the Analyst Price Target
Over the past 43 weeks, SANA's average price target has gone down $20.33.
Over the past 49 weeks, SANA's average upside potential has been 122.03%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-08-05 | 3 | 45 | 39 | 41.330 | 19.40 | 113.04% |
2021-09-18 | 3 | 45 | 31 | 37.500 | 24.98 | 50.12% |
2022-01-05 | 3 | 40 | 31 | 37.000 | 13.11 | 182.23% |
2022-02-03 | 2 | 40 | 17 | 29.333 | 7.64 | 283.94% |
2022-03-29 | 3 | 32 | 14 | 21.000 | 8.16 | 157.35% |
SANA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.83 | 1 | 1 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
SANA's average broker recommendation rating improved by 0 over the prior 120 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Sana Biotechnology Inc's number of analysts covering the stock is greater than 60.41% of them.
- In the context of all US stocks, Sana Biotechnology Inc's upside potential (average analyst target price relative to current price) is greater than 536.2% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Sana Biotechnology Inc's variance in analysts' estimates is lower than -330.83% of them.
- In the context of stocks in the mid market cap category, Sana Biotechnology Inc's average analyst price target is greater than 205.82% of them.
In the Pharmaceutical Products industry, RXRX, RVMD, and RUBY are the three stocks most similar to Sana Biotechnology Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for SANA? Use POWR Ratings for clearer insight into price direction.